AstraZeneca reported $16.2 billion Q3 revenue, up 7%, as oncology grew 17% and Farxiga fell 25% after US generics.
BL Cestrian Capital Research Oct 30 2 clicks
Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.
BL Cestrian Capital Research Oct 30 1 click
Bloom may have reopened imports of scandium-containing components from China to the United States, according to new trade data.
BL Hunterbrook Oct 30 4 clicks
Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.
S TSOH Investment Research Oct 30 1 click
Verisk Analytics’ 40 petabytes of proprietary insurance data and regulatory infrastructure shield its underwriting business from generative…
S First Strike Research Oct 30 7 clicks
Applied Materials posted 51% growth while trading near 23 times forward earnings; memory spending and fab construction support orders, but…
SA Capital Minded Oct 30 1 click Marvell’s reported Lumentum bid would combine DSPs, lasers and optical modules, but $4 billion of cash and $5 billion of debt point to a…
S Vik's Newsletter Oct 30 1 click
SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.
S WHAT ARE WE DOING? “Contrarians At The Gate” Oct 29 3 clicks
Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…
S Irrational Analysis Oct 29 2 clicks
Alphabet, Amazon and Intel face market pressure as the big three cloud giants reaffirm AI spending plans.
BL The Technology Letter Oct 29 1 click
Oracle rose about 12% intraday on October 28, 2026 as AI infrastructure and cloud-demand sentiment improved and credit-spread concerns…
BL Cestrian Capital Research Oct 28 2 clicks
Cerebras relies on OpenAI for almost all of its $25 billion backlog while renting AI capacity, raising questions over its semiconductor…
S Shallow Dives Oct 28 4 clicks
Danaher’s new CEO paired a Q3 beat and raised EPS outlook with a 2027 4%-5% organic-growth starting point, while pitching AI-enabled…
S Best Anchor Stocks Oct 28 1 click
Cigna faces PBM margin pressure as employer fee demands and Signature transition costs outweigh specialty-drug growth, limiting profit…
SA Narek Hovhannisyan Oct 28 1 click Vertiv beat Q3 revenue guidance by $460 million, grew organic sales 55%, and raised full-year revenue guidance by $650 million to a $14.65…
BL Cestrian Capital Research Oct 28 3 clicks
Alibaba's $100 valuation discounts cloud growth, China competition and US investment-ban risk, while its cloud unit posted 45% revenue…
SA M&M Capital Oct 28 2 clicks EQT moved to Distribute at $56.29 after Q3 revenue fell 9.6%; a 44% trailing free-cash-flow margin signals cycle risk despite lower debt…
BL Cestrian Capital Research Oct 27 2 clicks
Innodata shares fell 25% to $44.74 after India Today reported 550 job cuts in India.
BL The Technology Letter Oct 27 6 clicks
GFL’s take-private structure hinges on BC Partners rolling 60% of its stake to preserve debt portability under the 40% permitted-holder…
S 310 Value’s Newsletter Oct 27 5 clicks
Lumentum’s 2027 optical-chip expansion, 200G EML and CW capacity, silicon-photonics roadmap, pricing and 3.2T module prospects face…
S P Equity Research Oct 27 2 clicks